To Avoid Delay, the FDA Recommends CytoDyn Conduct

To Avoid Delay, the FDA Recommends CytoDyn Conduct Its Type A Meeting in Writing with FDA Response Goal Date of September 4

I don't see how Bruce's presence factored into the FDAs recommendation for a WRO (Written Response Only) Type A meeting.

https://www.fda.gov/media/109951/download

IV. MEETING FORMATS

There are three meeting formats: face to face, teleconference/videoconference, and WRO as follows:

(1)Face to face — Traditional face-to-face meetings are those in which the majority of attendees participate in person at the FDA

(2)Teleconference/Videoconference — Teleconferences/videoconferences are meetings in which the attendees participate from various remote locations via an audio (e.g., telephone) and/or video connection

(3)Written response only — WRO responses are sent to requesters in lieu of meetings conducted in one of the other two formats described above

In reality, there were only 2 options as option 1 is off the table due to COVID.

I'm optimistic that the FDA recommended the WRO meeting because the questions CytoDyn has are straightforward and shouldn't require a back and forth conversation. Given how stretched out the FDAs resources must be at the moment, it would also make sense that they're reserving teleconferences/videoconferences for COVID related matters.